Literature DB >> 9440796

Brain injury in the premature infant--from pathogenesis to prevention.

J J Volpe1.   

Abstract

Brain injury in the premature infant is an extremely important problem, in part because of the large absolute number of infants affected yearly. The two principal brain lesions that underlie the neurological manifestations subsequently observed in premature infants are periventricular hemorrhagic infarction and periventricular leukomalacia. The emphases of this article are the neurology, neuropathology and pathogenesis of these two lesions. Recent work suggests that the ultimate goal, prevention of the lesions, is potentially achievable. Periventricular hemorrhagic infarction may be preventable by prevention of germinal matrix-intraventricular hemorrhage, and periventricular leukomalacia, by detection of impaired cerebrovascular autoregulation, prevention of impaired cerebral blood flow and interruption of the cascade to oligodendroglial cell death by such agents as free radical scavengers.

Entities:  

Mesh:

Year:  1997        PMID: 9440796     DOI: 10.1016/s0387-7604(97)00078-8

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  27 in total

1.  Reader variability in the use of diagnostic terms to describe white matter lesions seen on cranial scans of severely premature infants: the ELGAN study.

Authors:  Sjirk Westra; Ira Adler; Daniel Batton; Bradford Betz; Steven Bezinque; Sara Durfee; Kirsten Ecklund; Kate Feinstein; Lynn Fordham; Joseph Junewick; Robert Lorenzo; Roy McCauley; Cindy Miller; Joanna Seibert; Karl Kuban; Elizabeth Allred; Alan Leviton
Journal:  J Clin Ultrasound       Date:  2010-10       Impact factor: 0.910

2.  Simultaneous Multi-VENC and Simultaneous Multi-Slice Phase Contrast Magnetic Resonance Imaging.

Authors:  Suhyung Park; Liyong Chen; Jennifer Townsend; Hyunyeol Lee; David A Feinberg
Journal:  IEEE Trans Med Imaging       Date:  2019-08-12       Impact factor: 10.048

3.  Cerebral Blood Flow Measured by Phase-Contrast Magnetic Resonance Angiography in Preterm and Term Neonates.

Authors:  Nienke Wagenaar; Lucas H Rijsman; Astrid Nieuwets; Floris Groenendaal
Journal:  Neonatology       Date:  2019-01-22       Impact factor: 4.035

Review 4.  Neurodevelopmental outcome in congenital diaphragmatic hernia: Evaluation, predictors and outcome.

Authors:  Enrico Danzer; Stephen S Kim
Journal:  World J Clin Pediatr       Date:  2014-08-08

5.  Determining Electrode Placement for Transcranial Direct Current Stimulation: A Comparison of EEG- Versus TMS-Guided Methods.

Authors:  Tonya L Rich; Jeremiah S Menk; Kyle D Rudser; Mo Chen; Gregg D Meekins; Edgar Peña; Timothy Feyma; Kay Bawroski; Christina Bush; Bernadette T Gillick
Journal:  Clin EEG Neurosci       Date:  2017-05-22       Impact factor: 1.843

Review 6.  Mechanism of Neuroprotection Against Experimental Spinal Cord Injury by Riluzole or Methylprednisolone.

Authors:  Cynthia Sámano; Andrea Nistri
Journal:  Neurochem Res       Date:  2017-12-30       Impact factor: 3.996

7.  Anisotropy of transcallosal motor fibres indicates functional impairment in children with periventricular leukomalacia.

Authors:  Inga Koerte; Paula Pelavin; Berit Kirmess; Teresa Fuchs; Steffen Berweck; Ruediger P Laubender; Ingo Borggraefe; Sebastian Schroeder; Adrian Danek; Claudia Rummeny; Maximilian Reiser; Marek Kubicki; Martha E Shenton; Birgit Ertl-Wagner; Florian Heinen
Journal:  Dev Med Child Neurol       Date:  2010-12-01       Impact factor: 5.449

8.  Neonatal intracerebral hemorrhage: mechanisms, managements, and the outcomes.

Authors:  P Bouz; A Zouros; A Taha; V Sadanand
Journal:  Transl Stroke Res       Date:  2012-06-06       Impact factor: 6.829

9.  Neurovascular coupling and energy metabolism in the developing brain.

Authors:  M Kozberg; E Hillman
Journal:  Prog Brain Res       Date:  2016-03-22       Impact factor: 2.453

10.  A decade comparison of preterm motor performance at age 4.

Authors:  Mary C Sullivan; Katheleen Hawes
Journal:  Res Nurs Health       Date:  2007-12       Impact factor: 2.228

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.